Skip to content

Comparing the effect of of Remifentanil and Apotel on postoperative pain in Total knee arthroplasty patients

Comparing the effect of of Remifentanil and Apotel on postoperative pain in Total knee arthroplasty patients (a clinical trial study)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220812055663N1
Enrollment
62
Registered
2022-11-14
Start date
2022-09-23
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee joint arthritis. Pain in joint

Interventions

Intervention 1: Intervention group: Group A (Apotel): For patients in this group, after spinal anesthesia and hemodynamic stability of the patient and the start of surgery, 1 gram of Apotel is poured

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: All candidate patients for knee joint replacement surgery referred to Amir-al-Momenin Hospital in Arak Patients in the age range of 18 to 60 years All patients undergo knee joint replacement by arthroplasty method Patients have informed consent

Exclusion criteria

Exclusion criteria: All patients whose duration of surgery is more than 150 minutes All patients in whom spinal anesthesia fails and have to undergo general anesthesia Patients with ASA class 3 and 4 sensitivity/allergy to local anesthetics, Apotel and opioids The patient has an underlying heart, lung, liver, kidney, etc. disease

Design outcomes

Primary

MeasureTime frame
Average post-operational Visual Analogue Scale(VAS) in patients. Timepoint: 2, 4, 8,12 and 24 hours after surgery. Method of measurement: Questionnaire.;Average duration of postoperative analgesia. Timepoint: Up to 24 hours after the operation. Method of measurement: Questionnaire.;Average opioid consumption after surgery. Timepoint: 24 hours after the operation. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
Average mean arterial pressure of patients in recovery. Timepoint: Duration of observation in recovery. Method of measurement: Monitor.;Average pulse rate of patients in recovery. Timepoint: Duration of observation in recovery. Method of measurement: Monitor.;Average SPO2 of patients in recovery. Timepoint: Duration of observation in recovery. Method of measurement: Monitor.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Ali Golrokh Moghadam

Arak University of Medical Sciences

gmoghaddam_ali@arakmu.ac.ir+98 86 3417 3520

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026